Results 121 to 130 of about 17,459 (201)

Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention. [PDF]

Hum Vaccin Immunother
Andani A, Abbing-Karahagopian V, Kavaliauskaite J, Schaffner TO, Sohn WY, Graña MG, Marshall H, Martinon-Torres F, Bonanni P, Rappuoli R, Taha MK.   +10 more
europepmc   +1 more source

Healthcare costs of invasive meningococcal disease: a nationwide population-based study using an innovative clustering method to identify sequelae. [PDF]

BMC Infect Dis
Duval X, Collin C, Baloche A, Fanchon L, Nora T, Hoen B.   +5 more
europepmc   +1 more source

A systematic review of demographic and socioeconomic characteristics associated with inequalities in invasive meningococcal disease prevention in high-income countries and Latin America. [PDF]

Hum Vaccin Immunother
Kocaata Z, Begum S, Andani A, Ubamadu IM, Rolland C.   +4 more
europepmc   +1 more source

Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada. [PDF]

Infect Dis Ther
Wolynn T, Grimes JB, Nerurkar S, Dawson R, Galarza K, Hassas H, Upegui A, Greenberg DP, Robertson CA, Entenmann H, Jones Mann E, Bennetts L, Neary MP.   +12 more
europepmc   +1 more source

First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. [PDF]

Euro Surveill
Foster K, Heymer EJ, Campbell H, Wilson E, Baldasera J, Lucidarme J, Clark SA, Bai X, Ahmad S, Borrow R, Ladhani SN.   +10 more
europepmc   +1 more source

Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025. [PDF]

Euro Surveill
Campbell H, Lucidarme J, Clark SA, Heymer EJ, Ribeiro S, Bai X, Ahmad S, Ramsay ME, Borrow R, Ladhani SN.   +9 more
europepmc   +1 more source

Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease Rebound. [PDF]

Vaccines (Basel)
Findlow J, Htar MTT, Villena R, Balmer P.   +3 more
europepmc   +1 more source

Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region. [PDF]

Hum Vaccin Immunother
Liu G, Gonzales MLAM, Chan WH, Memon IA, Alam A, Lee H, Wickramasinghe H, Pham QT, Dayal R, Levin M, Huang YC, Buttery J, Ong-Lim ALT, Kwan MYW.   +13 more
europepmc   +1 more source

Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA. [PDF]

Pharmacoeconomics
Shah HA, Jutlla G, Herrera-Restrepo O, Graham J, Grace M, Khan SA, Kuylen E, Begum S, Verelst F, Kocaata Z.   +9 more
europepmc   +1 more source

Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare <i>porA</i> genosubtype (19-54, 15), Spain, March to April 2024. [PDF]

Euro Surveill
Abad R, Navarro C, García-Amil C, Montes M, Castañeda-García A, Cuadros JA, Galar A, Martin F, Mena E, Pérez de Madrid S, Román C, Soler M, Vázquez JA.   +12 more
europepmc   +1 more source